Arkansas protected individual care in statute. Its malpractice rule points backward.
The Chronic Intractable Pain Treatment Act recognizes treatment according to the individual patient. Yet 17 CAR section 140-202 attributes a 50 MME definition of “excessive” prescribing to CDC. The clean opening move is a formal petition requiring the Medical Board to amend the rule or explain its refusal in writing.
Arkansas already wrote the better principle.
Individual patient
Arkansas law recognizes pain management as legitimate practice and protects treatment based on the needs and risks of the individual patient.
Numerical presumption
The malpractice rule calls prescribing at or above 50 MME excessive unless a detailed set of conditions is documented.
Thirty day answer
Arkansas law permits any person to petition for a rule amendment and requires rulemaking or a written denial within thirty days.
Do not ask Arkansas to invent individualized care. Ask it to reconcile its rule with the principle already enacted.
Separate protection, restriction, and evidence.
Protective statute
The Chronic Intractable Pain Treatment Act is the state’s affirmative access foundation. It must be read precisely, including its conditions and limits.
Binding professional rule
The Medical Board malpractice rule creates documentation and monitoring consequences for physicians and physician assistants.
Clinical guidance
CDC guidance informs risk assessment. It does not itself create Arkansas malpractice law or a state dosage ceiling.
Separate systems
Nursing, podiatry, pharmacy, Medicaid, workers compensation, and private institutions require their own authority records.
Start with the body that owns the first rule.
Arkansas State Medical Board. It owns 17 CAR section 140-202 and must receive the first petition.
The General Assembly enacted the Chronic Intractable Pain Treatment Act and can act if the Board identifies a barrier it cannot correct.
The Arkansas Medical Society and Arkansas clinicians can evaluate whether the CDC attribution and numerical presumption remain defensible.
Nursing and podiatric rules contain related numerical language. They become conforming tracks after the first Medical Board record exists.
The Arkansas Ethics Commission should answer any registration question before paid, reimbursed, or organized influence activity begins.
The statute speaks in patients. The rule speaks in presumptions.
Arkansas Code sections 17-95-701 through 17-95-707 recognize chronic intractable pain treatment as a legitimate part of medical practice. The law protects a physician from discipline based solely on appropriate controlled substance treatment and recognizes that a dose suitable for one condition or patient may differ from another.
17 CAR section 140-202 states that prescribing at or above 50 MME is excessive unless specified documentation, examinations, monitoring, testing, and agreement conditions are met. It presents that definition as pursuant to the CDC chronic pain guideline.
The 2022 CDC guideline says its recommendations are not a replacement for clinical judgment, an inflexible standard of care, a law, or a policy dictating practice.
Risk rises with dosage. That fact does not convert one number into a finding of malpractice.
Petition to amend 17 CAR section 140-202.
Correct the attribution
Remove the statement that CDC defined prescribing at or above 50 MME as excessive.
Remove the presumption
State that dosage alone does not establish excessive prescribing, malpractice, or a violation.
Preserve safeguards
Require documented assessment, clinical rationale, follow-up, and monitoring proportionate to the patient’s circumstances.
Reconcile the law
Expressly construe the rule consistently with the Chronic Intractable Pain Treatment Act and individualized patient need.
A narrow amendment with a real deadline.
Proposed replacement principle
Prescribing an opioid dosage at or above 50 morphine milligram equivalents per day shall not, by dosage alone, be deemed excessive prescribing or malpractice. The licensee shall document an individualized assessment of benefits and risks, the clinical rationale for treatment, and follow-up and monitoring appropriate to the patient’s circumstances. This section does not create a dosage ceiling and shall be construed consistently with the Chronic Intractable Pain Treatment Act.
Petition request
Under Arkansas Code section 25-15-204(d), please initiate rulemaking to amend 17 CAR section 140-202 using the proposed principle or deny this petition in writing within thirty days, stating the Board’s reasons and identifying the scientific and legal basis for retaining the current CDC attribution.
Turn the contradiction into an administrative record.
Clear the ethics question. Obtain written Arkansas guidance on whether planned advocacy, funding, travel, or public mobilization triggers registration or reporting.
Archive the law and rule. Preserve the current statutory text, 17 CAR section 140-202, CDC guidance, and the Board’s petition procedure with access dates.
File one complete petition. Identify the exact rule, requested amendment, supporting facts, legal conflict, scientific basis, and proposed language. Use provable delivery.
Calendar the deadline. Record the submission date and the thirtieth day. The answer should be rulemaking or a written denial with reasons.
Build clinical support. Invite Arkansas physicians and organized medicine to review the petition and state whether CDC defined 50 MME as excessive.
Use the Board’s answer. If rulemaking begins, participate constructively. If denied, use the reasons to define the next board, oversight, or legislative action.
Arkansas supplies a clock. Use it.
Correct the first rule, then trace its copies.
Medical Board
17 CAR section 140-202 is the first target because it governs the central physician and physician assistant malpractice standard.
Podiatric Board
A related rule uses materially similar CDC attribution and 50 MME language. The Podiatric Board must amend its own rule.
Nursing Board
APRN dosage and treatment rules contain related numerical and monitoring conditions. They require a separate petition and nursing record.
Payers and pharmacies
Medicaid, workers compensation, benefit managers, wholesalers, pharmacies, and health systems may impose additional controls that are not automatically state law.
Let the Board create the next step.
Submit evidence, propose exact text, recruit Arkansas clinical testimony, and answer objections on the public record.
Analyze every stated reason. Ask whether the Board claims statutory, scientific, federal, or administrative necessity.
Return the CDC’s own statement that the guideline is not an inflexible standard, law, or substitute for judgment.
Take that identified barrier, not a generalized complaint, to the General Assembly.
Stop escalating when transparent, good-faith rulemaking begins.
The claim is only as strong as the document behind it.
Arkansas Medical Practices Act, Statutes and RulesStatutory record
Arkansas Code section 25-15-204 · Rule Petition ProcedureThirty day process
CDC Clinical Practice Guideline for Prescribing Opioids for Pain, 2022Clinical benchmark
CDC Guideline at a GlanceUse limitations
Arkansas Ethics CommissionCompliance gate
Keep the accusation smaller than the evidence.
Confirmed
The rule uses a 50 MME definition of excessive prescribing and attributes it to CDC. Arkansas law also contains an individualized chronic pain treatment framework.
Not proven by the text
The rule alone does not prove how every clinician, investigator, payer, or pharmacy applies it in an individual case.
Method
Ask for adoption records, enforcement interpretations, complaint data, disciplinary use, cost analysis, and review of the 2022 CDC guideline. Publish what the record establishes. Label unanswered questions honestly.
The law already knows the patient is an individual.
Put that principle back into the rule. File precisely. Prove delivery. Make the Board answer.